Alnylam Pharmaceuticals I... (ALNY)
undefined
undefined%
At close: undefined
246.57
0.54%
After-hours Dec 13, 2024, 05:28 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
Revenue 1.83B 1.04B 844.29M 492.85M 219.75M 74.91M 89.91M 47.16M 41.10M 50.56M 47.17M 66.72M 82.76M 100.04M 100.53M 96.16M 50.90M 26.93M 5.72M 4.28M 176.00K -
Cost of Revenue 310.41M 168.82M 140.14M 78.05M 25.06M 1.80M 13.37M - - - - - - - - - - - - - - -
Gross Profit 1.52B 868.60M 704.14M 414.80M 194.69M 73.11M 76.55M 47.16M 41.10M 50.56M 47.17M 66.72M 82.76M 100.04M 100.53M 96.16M 50.90M 26.93M 5.72M 4.28M 176.00K -
Operating Income -282.18M -785.07M -708.65M -828.44M -939.43M -814.67M -500.09M -424.59M -296.01M -404.98M -92.94M -129.46M -54.82M -44.07M -48.11M -27.84M -93.18M -39.50M -43.47M -32.26M -25.06M -4.22M
Interest Income 95.56M 24.81M 1.58M 11.81M 33.45M 29.26M 12.24M 8.31M 5.86M 2.56M 1.07M 977.00K 1.21M 2.31M 5.38M 14.41M 15.39M - - - - -
Pretax Income -433.52M -1.13B -852.14M -855.60M -885.25M -760.67M -490.87M -410.11M -290.07M -400.60M -91.92M -116.59M -57.65M -43.00M -47.01M -25.53M -80.22M -34.61M -42.91M -35.37M -29.69M -
Net Income -440.24M -1.13B -852.82M -858.28M -886.12M -761.50M -490.87M -410.11M -290.07M -360.39M -89.22M -106.01M -57.65M -43.52M -47.59M -26.25M -85.47M -34.61M -42.91M -32.65M -25.03M -4.14M
Selling & General & Admin 795.65M 770.66M 620.64M 588.42M 479.00M 382.36M 199.37M 89.35M 60.61M 44.53M 27.15M 44.61M 38.28M 37.73M 39.91M 27.11M 23.39M 16.63M 13.87M 11.94M 7.53M 880.00K
Research & Development 1.00B 883.01M 792.16M 654.82M 655.11M 505.42M 390.63M 382.39M 276.50M 190.25M 112.96M 86.57M 99.30M 106.38M 108.73M 96.88M 120.69M 49.80M 35.32M 24.60M 13.10M 3.34M
Other Expenses - -109.37M -2.05M 45.52M 20.73M 4.17M -3.02M 6.17M 76.00K 1.82M -47.00K 331.00K - - - - - - - - - -
Operating Expenses 1.80B 1.65B 1.41B 1.24B 1.13B 887.78M 590.00M 471.75M 337.11M 234.78M 140.11M 131.18M 137.57M 144.11M 148.64M 124.00M 144.07M 66.43M 49.19M 36.54M 20.62M 4.22M
Interest Expense 121.22M 155.97M 143.02M 84.50M - 29.26M 12.24M 8.31M 5.86M 2.56M 1.07M 977.00K 1.21M 2.31M 5.38M 872.00K 1.08M - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - - - - -
Cost & Expenses 2.11B 1.82B 1.55B 1.32B 1.16B 889.58M 590.00M 471.75M 337.11M 234.78M 140.11M 131.18M 137.57M 144.11M 148.64M 124.00M 144.07M 66.43M 49.19M 36.54M 20.62M 4.22M
Income Tax 6.72M 4.16M 680.00K 2.68M 863.00K 823.00K -25.60M -23.44M -24.91M -40.21M -2.69M -10.57M -5.80M 514.00K 582.00K 719.00K 5.25M -4.89M -558.00K 390.00K 4.58M -86.00K
Shares Outstanding (Basic) 124.91M 121.69M 118.45M 114.99M 109.26M 100.59M 90.55M 85.60M 83.99M 74.28M 61.55M 50.29M 42.41M 42.04M 41.63M 41.08M 38.66M 31.89M 21.95M 11.89M 942.66K 331.34K
Shares Outstanding (Diluted) 124.91M 121.69M 118.45M 114.99M 109.26M 100.59M 90.55M 85.60M 83.99M 74.28M 61.55M 50.29M 42.41M 42.04M 41.63M 41.08M 38.66M 31.89M 21.95M 11.89M 942.66K 331.34K
EPS (Basic) -3.52 -9.3 -7.2 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 -2.21 -1.09 -1.96 -2.75 -26.56 -12.48
EPS (Diluted) -3.52 -9.3 -7.2 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -1.45 -2.11 -1.36 -1.04 -1.14 -0.64 -2.21 -1.09 -1.96 -2.75 -26.56 -12.48
EBITDA -258.24M -926.56M -661.56M -736.33M -868.08M -754.24M -488.19M -409.46M -276.96M -172.29M -82.71M -51.71M -49.69M -38.06M -41.02M -18.93M -75.06M -35.69M -38.83M -29.55M -19.61M -4.19M
Depreciation & Amortization 54.05M 44.47M 47.57M 34.77M 17.18M 6.43M 13.37M 15.13M 19.05M 11.93M 10.23M 9.04M 5.13M 4.94M 5.99M 5.73M 4.08M 3.81M 3.12M 2.44M 838.00K 36.00K